April 26, 2026
The US Food and Drug Administration issued national priority vouchers to three companies studying psychedelic-based medicines.
Continue readingThe US Food and Drug Administration issued national priority vouchers to three companies studying psychedelic-based medicines.
Continue readingKaiser Permanente study of nearly half a million adolescents finds cannabis use may precede onset of serious psychiatric disorders
Continue readingThe back-to-school season is a great time to engage with youth about mental health and substance use to promote their well-being throughout the academic year.
Continue readingMore American adults with mental health needs have been getting talk therapy in recent years, according to a new study published in the American Journal of Psychiatry.
Continue readingThe U.S. Food and Drug Administration just rejected an application that would have authorized the use of a promising psychedelic compound, MDMA, for the treatment of post-traumatic stress disorder, a condition affecting 13[…]
Continue readingAccording to the National Center for Drug Abuse, drug usage among teenagers rose 61% between 2016 and 2020.
Continue reading